Conversion of agonist site to metal-ion chelator site in the β2-adrenergic receptor

被引:98
作者
Elling, CE [1 ]
Thirstrup, K [1 ]
Holst, B [1 ]
Schwartz, TW [1 ]
机构
[1] Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark
关键词
D O I
10.1073/pnas.96.22.12322
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Previously metal-ion sites have been used as structural and functional probes in seven transmembrane receptors (7TM), but as yet ail the engineered sites have been inactivating. Based on presumed agonist interaction points in transmembrane III (TM-III) and -VII of the beta(2)-adrenergic receptor, in this paper we construct an activating metal-ion site between the amine-binding Asp-113 in TM-III-or a His residue introduced at this position-and a Cys residue substituted for Asn-312 in TM-VII. No increase in constitutive activity was observed in the mutant receptors. Signal transduction was activated in the mutant receptors not by normal catecholamine ligands but instead either by free zinc ions or by zinc or copper ions in complex with small hydrophobic metal-ion chelators. Chelation of the metal ions by small hydrophobic chelators such as phenanthroline or bipyridine protected the cells from the toxic effect of, for example Cu2+. and in several cases increased the affinity of the ions for the agonistic site. Wash-out experiments and structure-activity analysis indicated, that the high-affinity chelators and the metal ions bind and activate the mutant receptor as metal ion guided ligand complexes. Because of the well-understood binding geometry of the small metal ions, an important distance constraint has here been imposed between TM-III and -VII in the active, signaling conformation of 7TM receptors. it is suggested that atoxic metal-ion chelator complexes could possibly in the future be used as generic, pharmacologic tools to switch 7TM receptors with engineered metal-ion sites on or off at will.
引用
收藏
页码:12322 / 12327
页数:6
相关论文
共 34 条
[1]   An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors [J].
Baldwin, JM ;
Schertler, GFX ;
Unger, VM .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 272 (01) :144-164
[2]   THE PROBABLE ARRANGEMENT OF THE HELICES IN G-PROTEIN-COUPLED RECEPTORS [J].
BALDWIN, JM .
EMBO JOURNAL, 1993, 12 (04) :1693-1703
[3]   How receptors talk to trimeric G proteins [J].
Bourne, HR .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :134-142
[4]   PINDOLOL - THE PHARMACOLOGY OF A PARTIAL AGONIST [J].
CLARK, BJ ;
MENNINGER, K ;
BERTHOLET, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 :S149-S158
[5]   Engineering of metal-ion sites as distance constraints in structural and functional analysis of 7TM receptors [J].
Elling, CE ;
Thirstrup, K ;
Nielsen, SM ;
Hjorth, SA ;
Schwartz, TW .
FOLDING & DESIGN, 1997, 2 (04) :S76-S80
[6]   CONVERSION OF ANTAGONIST-BINDING SITE TO METAL-ION SITE IN THE TACHYKININ NK-1 RECEPTOR [J].
ELLING, CE ;
NIELSEN, SM ;
SCHWARTZ, TW .
NATURE, 1995, 374 (6517) :74-77
[7]   Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering [J].
Elling, CE ;
Schwartz, TW .
EMBO JOURNAL, 1996, 15 (22) :6213-6219
[8]   Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin [J].
Farrens, DL ;
Altenbach, C ;
Yang, K ;
Hubbell, WL ;
Khorana, HG .
SCIENCE, 1996, 274 (5288) :768-770
[9]   Agonists induce conformational changes in transmembrane domains III and VI of the beta(2) adrenoceptor [J].
Gether, U ;
Lin, S ;
Ghanouni, P ;
Ballesteros, JA ;
Weinstein, H ;
Kobilka, BK .
EMBO JOURNAL, 1997, 16 (22) :6737-6747
[10]  
GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1